Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01597063 · ClinicalTrials.gov registry record
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
A clinical trial, sponsored by Sequenom.
- Completed
- Registry status
- 3,333
- Enrollment target
NCT01597063 is a clinical trial that has completed, run by Sequenom. The registered enrollment target is 3,333 participants.
The verdict
NCT01597063 has completed, sponsored by Sequenom.
- COMPLETED
- Registry status
- 3,333 participants
- Enrollment target
Study Summary
Pregnant women with low risk indicators for fetal chromosomal aneuploidy will be enrolled. Study blood will be collected in the first or second trimester at a scheduled prenatal screening visit, processed to plasma, and stored frozen until analysis. Each pregnancy will be followed until delivery and the birth outcome recorded.
Interventions
- DEVICE SEQureDx Trisomy Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,333 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01597063
The ClinicalTrials.gov registry entry for NCT01597063 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sequenom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SEQureDx Trisomy Test is the first listed.
NCT01597063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01597063 about?
NCT01597063 is a clinical study titled "Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies". Pregnant women with low risk indicators for fetal chromosomal aneuploidy will be enrolled. Study blood will be collected in the first or second trimester at a scheduled prenatal screening visit, processed to plasma, and stored frozen until analysis. Each pregnancy will be followed until delivery and...
What is the current status of trial NCT01597063?
This trial is currently completed. The enrollment target is 3,333 participants. The study started on 2012-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01597063?
The interventions under investigation include: SEQureDx Trisomy Test (DEVICE).
Who is sponsoring clinical trial NCT01597063?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.